AKT1 and Familial prostate cancer: However, there is no conclusive evidence of the modulation of the PI3K/Akt pathway in PC3 and LNCaP prostate cancer cell lines, since they have a constitutive activation of PI3K/Akt pathway due to the deletion of the tumor suppression gene, PTEN 15, 94.